Tvardi Therapeutics, Inc.

TVRD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Aug 14, 2026 10-Q
8-K Aug 14, 2026 FORM 8-K
8-K Jul 30, 2026 FORM 8-K
8-K Jul 17, 2026 FORM 8-K
424B5 Jul 17, 2026 424B5
8-K Jul 7, 2026 FORM 8-K
4 Jun 11, 2026
4 Jun 11, 2026
4 Jun 11, 2026
4 Jun 11, 2026
4 Jun 11, 2026
8-K Jun 11, 2026 FORM 8-K
EFFECT May 13, 2026
EFFECT May 12, 2026
POS AM May 8, 2026 POS AM
CORRESP May 8, 2026
10-Q May 8, 2026 10-Q
8-K May 8, 2026 FORM 8-K
UPLOAD May 7, 2026
S-3 May 1, 2026 S-3
ARS Apr 23, 2026 ARS
DEFA14A Apr 23, 2026 DEFA14A
DEF 14A Apr 23, 2026 DEF 14A
S-8 Apr 1, 2026 FORM S-8
POS EX Apr 1, 2026 POS EX
← Newer Page 1 of 33 · 809 filings Older →